Nano Dimension Ltd Sponsored ADR Stock News

Core Business Revenue of $14.4 Million, 8% Higher Year-Over-Year Conference Call Today at 4:30 PM EDT WALTHAM, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd.

Waltham, Massachusetts, June 11, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, has appointed two technology and growth experts, Andy Sriubas and Eileen Tanghal, to its Board of Directors. The appointments come at a pivotal moment as the Company shifts from M&A integration to scaling a unified technol...

Call to Be Held Thursday, June 12 at 4:30 PM EST Waltham, Massachusetts, June 10, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today announced it will host a conference call and webcast to discuss its Q1 2025 financial results for the period ended March 31, 2025.

Nano Dimension Ltd. (NASDAQ:NNDM ) Q4 2024 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Ofir Baharav - Chief Executive officer Assaf Zipori - Chief Financial Officer Julien Lederman - Chief Business Officer Conference Call Participants Greg Palm - Craig-Hallum Capital Group Jamison Lyngstad - Whitebox Operator Good day, ladies and gentlemen, welcome to Nano Dimension'...

Outlines Disciplined Strategy to Position Nano Dimension as a Digital Manufacturing Leader Benefiting From the Global Trade and Production Realignment

Call to Be Held Wednesday, April 30 at 4:30 PM EST Waltham, Massachusetts, April 28, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today announced it will host a conference call and webcast to discuss its 2024 financial results for the 2024 period ended December 31, 2024, and provide an outlook for t...

The 'Undercovered' Dozen highlights 12 lesser-covered stocks, offering investment opportunities and fostering community discussion on their potential. Abeona Therapeutics is seen as a Buy due to promising FDA approvals for pz-cel and UX111, potentially transforming the company with its first commercial products by 2025. Plains GP Holdings offers stable cash flows and high dividends in the volat...

Company Gains Strong Foothold in Metal and Composite Manufacturing Solutions for Manufacturing Floors and Takes Leap Forward in AI-Enhanced Manufacturing